OFFICIAL BIBLIOGRAPHY
- 1. **Bischoff. 2023.** “ESPEN Guideline on Clinical Nutrition in Inflammatory Bowel Disease.” Clinical Nutrition.
- 2. **Bischoff.** “ESPEN Practical Guidelines: Clinical Nutrition in Chronic Inflammatory Bowel Disease (IBD).”
- 3. **Magavi. 2022.** “Incorporating Nutrition-Based Strategies into IBD Treatment.” Current Gastroenterology Reports, October 20.
- 4. **Chouraki. 2011.** “The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age group (1988–2007).” *Alimentary Pharmacology & Therapeutics*, 33, no. 10 (March 16): 1133–42.
- 5. **AMICI Italia. n.d.** “Crohn’s Disease.”
- 6. **Singh. 2022.** “Evaluation of Nutritional Characteristics Reveals Similar Prevalence of Malnutrition Patients with Ulcerative Colitis and Crohn’s Disease.” *Digestive Diseases and Sciences*, September 5.
- 7. **ESPEN FACT SHEETS. n.d.** “DISEASE-RELATED MALNUTRITION DRM): A Neglected Threat for Every Patient—Nutritional Care Matters.”
- 8. **Dhaliwal. 2021.** “Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview.” Nutrients, 13, no. 2 (February 17): 656.
- 9. **Burisch. 2018.** “Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.” Gut, 68, no. 3 (January 23): 423–33.
- 10. **Ministry of Health. 2025.** “GUIDELINES ON Food for special medical purposes FSMPs). Revised July 15, 2025.”
- 11. **SINPE, SIGENP. n.d.** “The specifications for the enteral nutrition procurement bid.”
- 12. **Rinninella. 2023.** “Botanicals in human nutrition: a focus on the effects of bioactive food-derived compounds on the gut microbiota in gastrointestinal inflammatory diseases.” *Nutrimentum et Curae*, no. 02, e134.
- 13. **Loy. 2024.** “Dietary Fiber in Inflammatory Bowel Disease: Are We Ready to Change the Paradigm?”. *Nutrients*, 16, no. 8 (April 10): 1108.
- 14. **Feldheiser. 2015.** “Enhanced Recovery After Surgery (ERAS) for Gastrointestinal Surgery, Part 2: Consensus Statement for Anesthesia Practice.” *Acta Anaesthesiologica Scandinavica*, 60, no. 3 (October 30): 289–334.
- 15. **Hoshimoto. 2002.** “Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: a comparison with the potent histone deacetylase inhibitor trichostatin A.” British Journal of Pharmacology, 136, no. 2 (May): 280–86.
- 16. **Hashash, 2024.** “AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.” *Gastroenterology*, January.
- 17. **Massironi. 2023.** “Inflammation and malnutrition inflammatory bowel disease.” *Lancet Gastroenterology & Hepatology*, March.
- 18. **Di Stefano. 2024.** “T.11.1: Micronutrient Nutritional Deficiencies in Patients with Inflammatory Bowel Disease in Remission Following Long-Term Biologic Treatment.” Digestive and Liver Disease, 56 (April): S276.
- 19. **ESPEN FACT SHEETS. n.d.** “GLIM criteria for the diagnosis of malnutrition. A consensus report from the global clinical nutrition community”.
- 20. **Lombardy Region. 2024.** “Appendix A. Resolution XII/1812. Approved on January 29, 2024.”
- 21. **Pennings. 2011.** “Whey protein stimulates postprandial muscle protein accretion more effectively than casein and casein hydrolysate in older men.” American Journal of Clinical Nutrition, 93, no. 5 (March 2): 997–1005.
- 22. **AMICI Italia. n.d.** “Ulcerative Colitis.”
- 23. **Caterina Fazion. (2024. 2024.** “Chronic Intestinal Diseases: Symptoms Out of Control in Half of All Cases.”
- 24. **Panorama della Sanità. 2022.** “Crohn’s Disease and Ulcerative Colitis: The Number of Patients Is Expected to Double by 2030.” May 20, 2022.
- 25. **Ministry of Health. n.d.** “Conference for World Chronic Intestinal Diseases Day.”
- 26. **Cárdenas. 2022.** “Nutritional care is a human right: Translating principles to clinical practice.” *Nutrition in Clinical Practice*, May 23.
- 27. **Lombardy Region. 2024.** “IMPLEMENTATION OF THE NUTRITIONAL SCREENING PROGRAM IN REGIONAL HEALTH SERVICE FACILITIES AND HOME CARE SETTINGS. Resolution XII/1812. Approved on January 29, 2024.”
- 28. **ASPEN, ESPEN, FELANPE. 2022.** “The International Declaration on the Human Right to Nutritional Care.”
- 29. **ESPEN FACT SHEETS. n.d.** “Vienna Declaration.”
- 30. **Lionhealth.**
- 31. **Saibeni. 2023.** “Nutritional care at centers treating patients with inflammatory bowel disease: A nationwide survey in Italy.” *Digestive and Liver Disease*, June.
- 32. **Bezzio. 2024.** “Prevalence, Risk Factors, and Association with Clinical Outcomes of Malnutrition Sarcopenia in Inflammatory Bowel Disease: A Prospective Study.” *Nutrients*, 16, no. 23 (November 21): 3983.
- 33. **Cammarota. 2024.** “Review Article: Green Management of IBD—New Paradigms for an Eco-Friendly Approach.” *Alimentary Pharmacology & Therapeutics*, November 18.
- 34. **AMICI Italia & SINPE. n.d.** “MALNUTRITION IN CHRONIC INFLAMMATORY BOWEL DISEASES (IBD): PRELIMINARY RESULTS OF THE 2024 AMICI ITALIA SURVEY.”
- 35. **Falcone. n.d.** “Malnutrition and Chronic Inflammatory Bowel Diseases (IBD): The Need for a National Regulatory Framework to Ensure Equity in Nutritional Care.”
- 36. **Fiorindi. 2020.** “GLIM Criteria for Malnutrition Surgical IBD Patients: A Pilot Study.” Nutrients, 12, no. 8 (July 25): 2222.
- 37. **Casanova. 2017.** “Prevalence of Malnutrition Nutritional Characteristics of Patients With Inflammatory Bowel Disease.” Journal of Crohn’s and Colitis, 11, no. 12 (July 24): 1430–39.
- 38. **Pradelli. 2022.** “Prevalence and economic cost of malnutrition Italy: a systematic review and meta-analysis by the Italian Society of Artificial Nutrition and Metabolism (SINPE).” Nutrition, December, 111943.
- 39. **Elia. 2016.** “A systematic review of the cost and cost-effectiveness of using standard oral nutritional supplements in community and care home settings.” Clinical Nutrition, 35, no. 1 (February): 125–37.
- 40. **NICE. 2017.** “Nutrition support for adults: oral nutrition support, enteral tube feeding, and parenteral nutrition (CG32).” Clinical Guideline.
- 41. **Philipson. 2013.** “OP015 IMPACT OF ORAL NUTRITIONAL SUPPLEMENTATION ON HOSPITAL OUTCOMES.” Clinical Nutrition, 32 (September): S6–S7.
- 42. **Brennan. 2018.** “Does preoperative enteral or parenteral nutrition reduce postoperative complications in patients with Crohn’s disease?” European Journal of Gastroenterology & Hepatology, 30, no. 9 (September): 997–1002.
- 43. **Niccolai. n.d.** “The ESG Dimension in Bidding: The Green and Social Approach in Public Procurement. The Role and Experience of Central Purchasing Agencies.”
- 44. **Ministry of Health. 2024.** “Dietary Supplements and Ministerial Guidelines (LGM).”
- 45. **European Union.** “a. Regulation (EC) No. 1924/2006. Adopted on December 20, 2006. Official Journal of the European Union.”
- 46. **Ansell. 2008.** “Pharmacology and Management of Vitamin K Antagonists.” Chest, 133, no. 6 (June): 160S–198S.
- 47. **Forbes. 2017.** “ESPEN guideline: Clinical nutrition in inflammatory bowel disease.” *Clinical Nutrition*, 36, no. 2 (April): 321–47.
- 48. **Barazzoni. 2022.** “Guidance for the assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition GLIM) diagnosis of malnutrition.” Clinical Nutrition, April.
- 49. **European Union. 2013.** “REGULATION (EU) No. 609/2013. Adopted on June 12, 2013. Official Journal of the European Union.”
- 50. **European Union. 2015.** “DELEGATED REGULATION (EU) 2016/128. Adopted on September 25, 2015. Official Journal of the European Union.”
- 51. **Ministry of Health.** “GENERAL DIRECTORATE FOR FOOD HYGIENE, SAFETY, AND NUTRITION – OFFICE 4. Revised November 2018. n.d. Guidelines on studies conducted to assess the safety and properties of food products.”
- 52. **Muscaritoli. 2017.** “Prevalence of malnutrition patients at their first medical oncology visit: the PreMiO study.” Oncotarget, 8, no. 45 (August 10): 79884–96.
- 53. **Muscaritoli. 2021.** “ESPEN Practical Guidelines: Clinical Nutrition in Cancer.” SINPE.
- 54. **Pedrazzoli. 2024.** “NUTRITIONAL SUPPORT FOR PATIENTS UNDERGOING ACTIVE THERAPY.” AIOM GUIDELINES.
- 55. **Elia. 2018.** “Cost-effectiveness of oral nutritional supplements in older malnourished care home residents.” Clinical Nutrition, 37, no. 2 (April): 651–58.
- 56. **ANAC. 2017.**
- 57. **Hatamzade Esfahani. 2023.** “The Role of TGF-β, Activin, and Follistatin in Inflammatory Bowel Disease.” *Gastrointestinal Disorders*, 5, no. 2 (April 11): 167–86.
- 58. **Barberio. 2025.** “Dietary Interventions and Oral Nutritional Supplementation in Inflammatory Bowel Disease: Current Evidence and Future Directions.” Nutrients, 17, no. 11 (May 30): 1879.
- 59. **Fiorino. 2025.** “Adaptation of the European Crohn’s and Colitis Organization’s quality-of-care standards to Italy: The Italian Group for the Study of Inflammatory Bowel Disease Consensus.” *Digestive and Liver Disease*, April.
- 60. **Italy. 2017.**
- 61.Malnutrition Healthcare Costs in Hospitalized Patients with Inflammatory Bowel Disease: A Nationwide Real-World Data Analysis.**
- 62. **Oral Nutritional Supplementation Following Upper Gastrointestinal Cancer Surgery: A Prospective Analysis Exploring Potential Barriers to Compliance.**
- 63. **MUST Questionnaire. 2003.**
- 64. **AIOM. 2024.** “Cancer Statistics in Italy 2024.”
- 65. **UNIAMO Federation.**
- 66. **September.**
- 67. **World COPD Day.**
- 68. **Chen. 2025.** “The efficacy of infliximab combined with partial enteral nutrition in the treatment of Crohn’s disease.” Frontiers in Nutrition.
- 69. **WHO Europe.** “Disease-Related Malnutrition: A Time for Action”.
- 70. **Grand View Research. 2018.** “Europe Medical Foods Market Analysis, 2018–2030”.
- 71. **Deng M.** “Global Prevalence of malnutrition Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.” Clinical Nutrition.
- 72. **BAPEN.** “BAPEN MUST Toolkit.”
- 73. **Cruz-Jentoft. 2019.** “Sarcopenia: revised European consensus on definition and diagnosis.” *Age and Ageing*, 48, no. 1 (January): 16–31.
- 74. **Rare Diseases Observatory. 2024.** “Chronic Inflammatory Bowel Diseases in Italy: 250,000 Patients.” May 21.
- 75. **AMICI Italia. 2026.** “AMICI Italia 2026 Survey.” Data on file, in press.
- 76. **Ministry of Health. 2025.** “Explanatory Report: First Update to the Decree of the President of the Council of Ministers of January 12, 2017, on Essential Levels of Care.”
- 77. **Beaudart. 2017.** “Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis.” PLoS One, January 17.
- 78. **Beaudart. 2023.** “Sarcopenia and health-related quality of life: A systematic review and meta-analysis.” Journal of Cachexia, Sarcopenia and Muscle, June.
- 79. **Calvez. 2024.** “Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease.” Biomedicines, 12, no. 6: 1218.
- 80. **Feng. 2024.** “Sarcopenia and treatment failure in inflammatory bowel disease: a systematic review and meta-analysis.” Revista Española de Enfermedades Digestivas, 116, no. 2 (February): 68–76.
- 81. **Kuzuya. 2025.** “Nutritional Management Guidelines for Sarcopenia and Frailty 2025.” Geriatrics & Gerontology International, 25: 5–53.
- 82. **Pozzi. 2026.** “Nutritional Management of a Patient with Crohn’s Disease Following Ileocecal Resection and Severe Malnutrition.” Nutrients & Supplements, February.
- 83. **Arends. 2024.**Malnutrition cancer patients: Causes, consequences, and treatment options.” European Journal of Surgical Oncology.
